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Abstract
Background: Malignant tumours of minor salivary glands are uncommon, representing only 2-4% of all head and
neck cancers. In the larynx, minor salivary gland tumours rarely occur and constitute less than 1% of laryngeal
neoplasm. Most of the minor salivary gland tumours arise in the subglottis; however, they can also occur in the
supraglottis, in the false vocal cords, aryepiglottic folds and caudal portion of the epiglottis. The most common
type of malignant minor salivary gland tumour is adenoid cystic carcinoma.
Methods: We present a unusual case of adenoid cystic carcinoma of glottic-subglottic region in a 61-year-old
woman. Follow-up endoscopy and laryngeal magnetic resonance imaging (MRI) at three years after treatment
showed no recurrence of the tumour.
Results: The diagnosis of glottic-subglottic adenoid cystic carcinoma should be considered in patients who are
characterized by dyspnea, cough and stridor, but do not respond to pharmacologic approach.
Conclusions: Adenoid cystic carcinoma is usually a very slow growing cancer, invested by an apparently normal
laryngeal mucosa, so that it can show no clear symptoms for a long time. For these reasons the increasing number
of diagnostic mistakes or late diagnosis that may be fatal in some cases.
Introduction
Adenoid cystic carcinoma is the predominant histologic
type among malignancies of the minor salivary glands,
with a frequency of 10-20%, representing only 2-4% of
all head and neck malignancies [1,2]. In the population
the higher incidence is characteristic for women, espe-
cially between 50/60 years. There are no distinct risk
factors that predispose patients to this malignancy.
Smoking does not affect the incidence [3,4]. Its predo-
minant site is in the salivary glands of the oral cavity, in
particular in the hard palate and whit lesser frequency
in the nasal cavity, paranasal sinuses, pharynx and lar-
ynx, in this last localization is incredibly rare (0.07 %-
0.25% of all laryngeal tumours, 1% of all ACC), there
are a few salivary glands in the mucosa of laryngeal-
tracheal tract [2,3,5]. Only 174 cases of ACC in the lar-
ynx have been reported in literature reviews, with a per-
centage of incidence, in the anatomic laryngeal subsites
as follows : supra-glottis region (25%), glottis region
(5%), transglottic area (6%), sub-glottis region (64%).
The local diffusion is frequently infiltrating, with a slow
evolution and a large local invasiveness (thyroid/esopha-
gus); it’s possible, anyway, the exophytic or polipoid
growth of cancer in particular in the laryngeal-tracheal
site [6]. The dyspnea is often the predominant symptom
and the local-regional metastases, at least for malignan-
cies originated from subglottis region, are almost rare.
The average survival is about eight years. The evolution
prognosis of this disease is caused by lungs, bones and
brain metastases or by local recurrence, so thanks to
slow tumour growth, it sometimes could recur after ten
or more years [7]. We report a case of ACC, treated as
nodular benign thyroid neoplasm, in a patient whit pre-
vious diagnosis of asthma.
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Case report
A.N, 61 year-old woman, with an ACC injury in the
glottis-subglottis region, has been examined after a sur-
gical treatment of thyroid. The clinical appearance of
thyroid cancer is that of a nodules, some time represent-
ing a challenging diagnostic dilemma with thyroid or
unusual extrathyroidal masses [8,9]. The patient, suffer-
ing from severe dyspnea, was seen by the general sur-
geon at first, because she was affected by a thyroid
disease, causing compression, dislocation and reduction
of tracheal caliber. The ultrasound exam of thyroid con-
firmed a nodularity and the functionality exams showed
an evident dysfunction of gland. The FNAC, made in
hospital, didn’t show diagnostic significance. The fiber-
laryngoscopy control, effected before thyroidectomy,
reported a moderate reduction of hypoglottic space,
associated with a vocal cord hypomobility, especially on
the left. The persistence of dyspnea, after the thyroidect-
omy, and the final pathological examination characteris-
tic for ACC, made us doubt about the origin of lesion
in that site. The patient arrived to our observation for a
further diagnostic analysis. In fact, the fiberopticlaryngo-
scopy showed an hypertrophy of a left vocal fold, in the
midline position, with a slightly uneven surface, ipsilat-
eral hypoglottic region and subcommissurale region
neoformation and narrowing of the lumen (Figure 1).
The subsequent cervicothoracic CT shows a nodular
lesion of left part of larynx, associated with partial
destruction of thyroid cartilage, cricoid ring to the left
and ipsilateral arytenoid cartilage, in presence of bilat-
eral cervical lymph node hyperplasy (Figure 2). Accord-
ing to the clinical and radiologic data, the patient was
submitted to a total laryngectomy with functional bilateral
lymph node excision of II-III-IV-V-VI level (Figure 3).
The pathological examination confirmed a adenoid cystic
carcinoma deeply infiltrating the laryngeal mucosa, cricoid
carticalgine and striated muscle tissue present, with a
predominantly cribiform pattern, consisting of pseudo-
cytos, filled with mucin basophilic basaliod cells, sur-
rounded by areas of intra-tumoural necrosis and absence
of cervical lymphnode metastases (Figure 4). According
to the histological evaluation and to neoplastic involve-
ment (T3N0), the patient underwent to radioterapy on
“T” and “N”, with a total dose of 66GY, subdivision in
200cGy/die. The clinical and radio follow up after 6, 12,
24, and 36 months, consisting of ultrasound, TC, PET
total body, showed the absence of recurrence. No images
are shown of the primitive residue, referring to glottis -
subglottic ACC.
Discussion
Aging is accompanied by a increased incidence of mor-
tality from many diseases like cancer, diabetes, neurode-
generative, cardiovascular and other pathologies all
related to oxidative stress and elevated ROS (Reactive
oxygen species) [10,11]. Drugs, chemicals, pollutants,
high-caloric diets, exercise and sport activity are stress
agents involved in overproduction of oxidant molecules
[12]. The most common malignancy of the larynx is
squamous cell carcinoma. Median age of occurrence is
in the sixth and seventh decades and less than 1% of lar-
yngeal cancers arise in patients younger than 30 years of
age. Less commonly, other epithelial, neuroendocrine,
and soft tissue tumours can also occur in this location
[13,14]. Laryngeal salivary gland carcinomas are rare dis-
eases, cause the low density of minor glands in the lar-
ynx (between 23 and 47 glands/cm2) accounting for less
than 1% of all laryngeal malignancies, the most common
type is adenoid cystic carcinoma [15,16]. No distinct
risk factor that predisposes patients towards this malig-
nancy has been identified [3]. Smoking does not affect
Figure 1 Fiberlaryngoscopic finding that show a ACC of left
vocal fold.
Figure 2 CT scan of larynx showing left vocal cord mass and
destruction at left side of thyroid cartilage.
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Figure 3 Total laryngectomy with functional bilateral lymph node excision of II-III-IV-V-VI level.
Figure 4 The figures show adenoid cystic carcinoma deeply infiltrating the laryngeal mucosa. The tumour shows a predominant
cribiform pattern, and is composed of pseudocysts, filled with basophilic mucin, surrounded by basaloid cells a, b.. Areas of intra-tumoural
necrosis are also present. The lesion involves the cartilage (c) and the striated muscle (d) (Hematoxylin - eosin; a: 50X; b: 100x; c:200x; d:200x)
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the incidence differently from what happens for squa-
mous cell carcinoma [4]. According to Dexemble et al.
(2003) laryngeal ACC arises in sub-glottis area, which
could be an isolated site of neoplasm (60%) or could be
invaded by glottis or supra-glottis neoplasm (20%)
[6,15]. Neck metastasis are rare (10 to 15% of the cases),
but distant recurrence is common mainly to the lung
and may occur many years after the primary neoplasm
surgical treatment [3,16]. Adenoid cystic carcinoma is
usually a very slow growing cancer, invested by an
apparently normal laryngeal mucosa, so that it can show
no clear symptoms for a long time. For these reasons
the increasing number of diagnostic mistakes or late
diagnosis that may be fatal in some cases [4]. The symp-
tomatic square such as dyspnea, dysphagia and dyspho-
nia becomes clear in the respective supraglottic, glottic,
hypoglottic sites and it is the most insidious form above
all, in case of a late diagnosis. The signs and symptoms
of laryngeal adenoid cystic carcinoma are related to
location and size. Tumours of the supra-glottis present
with dysphagia. Hoarseness or even dyspnea is indicative
of glottic involvement. Stridor and airway obstruction
are more frequently associated with sub-glottic tumours.
However, usually, adenoid cystic carcinoma occurs as a
large asymptomatic, non-ulcerated sub-mucosal mass.
As a result, diagnosis is often delayed and, in the larynx,
sub-glottic tumours have the opportunity to invade dee-
ply before they are diagnosed [2]. The slowly insurgent
dyspnea together with laryngeal screeching may lead to
an early diagnose of asthma and if the symptoms don’t
disappear despite the adeguate therapy, radiological find-
ing such as CT is always most important for the diagno-
sis [5]. The direct invasion of the thyroid by the ACC
caused by the laryngotracheal complex simulating a
nodular benign pathology of the thyroid, just like the
case we have discussed so far, is a rare occurrence that
can delay the diagnosis [17]. The histopathological pat-
tern of adenoid cystic carcinoma is classified into three
distinct subtypes: cribriform, which is the most common
form and characterize case described here, tubular,
which has the best prognosis; and solid, which carries
the worst prognosis [3]. The five-year survival rates for
patients with laryngeal Adenoid Cystic Carcinoma have
been reported in literature to range from only 12 to
17% after surgery [3,4]. Surgical excision is the main
treatment due to the relative radioresistance of these
tumours [2,18]. Total laryngectomy assures radical
tumour excision and is often required because of
submucosal spread, lymphatic diffusion and perineural
invasion [2]. Postoperative radiation therapy is recom-
mended, since radiotherapy has shown result in
prolonging survival and preventing local recurrences
[19]. The use of Standard chemotherapies have systemic
toxicities and limited efficacy in the case of larynx
carcinoma as well as of other more common solid
tumours [20,22]. Some authors have reported positive
responses to chemotherapy, recommending it as pallia-
tive therapy in advanced cases [23]. Conversely, there is
no hint of a remodeling of the Ca2+ toolkit, that has
been observed in other malignancies, including renal
cellular carcinoma [24,25] and prostate cancer [26], and
has been put forward as alternative target for selective
molecular therapies [23].
Conclusion
Laryngeal salivary gland carcinomas are rare and account
for < 1% of laryngeal malignancies. Therefore, a high
degree of suspicion is essential for early diagnosis. This
tumour must be considered when aggressive laryngeal
tumours are found, especially if the patient is not at risk
for squamous cell carcinomas. They usually originate in
the supra-glottic or sub-glottic area with a predominance
of old age. Most patients are diagnosed late, at an
advanced stage. CT can be used to assess tumour extent
and growth patterns. Wide-margin surgery alone or in
combination with post-operative radiotherapy for
advanced lesions that present peri-neural spread or close
or positive margins is the best tumour management. For
these patients, regular and long-term follow-up is manda-
tory, in order to detect relapses and metastases.
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